Product correctly added to cart.

discount label
Ivacaftor hydrate
View 3D

Biosynth logo

Ivacaftor hydrate

CAS: 1134822-07-3

Ref. 3D-JVB82207

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Monday 10 Jun 2024

Product Information

Name:
Ivacaftor hydrate
Description:

Ivacaftor is a small molecule that inhibits the CFTR protein. It is used as a research tool to study the function of CFTR and as an experimental treatment for cystic fibrosis. Ivacaftor is a potent, selective inhibitor of the CFTR protein with activity against all known mutations in the CFTR gene, including those that confer resistance to other drugs. Ivacaftor is not an agonist or antagonist, but instead blocks the channel by binding at its open state. The efficacy of ivacaftor was demonstrated in animal models and in clinical trials involving patients with cystic fibrosis who have specific mutations in their CFTR gene.
Ivacaftor has been shown to be effective in treating symptoms of cystic fibrosis such as pulmonary exacerbations, weight loss, and sweat chloride levels.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
410.5 g/mol
Formula:
C24H30N2O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-JVB82207 Ivacaftor hydrate

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".